StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Lisata Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Lisata Therapeutics's market cap was $10.94M on Nov 11, 2026, against $18.04M a year earlier. Over the last 5 years it ranged from $9.02M to $50.31M, with a median of $24.42M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$10.94M-32.8%
2025Dec 31, 2025$16.29M-34.3%
2024Dec 31, 2024$24.79M+11.6%
2023Dec 29, 2023$22.22M+11.7%
2022Dec 30, 2022$19.89M-60.5%
2021Dec 31, 2021$50.31M+81.3%
2020Dec 31, 2020$27.75M+6.2%
2019Dec 31, 2019$26.13M-25.5%
2018Dec 31, 2018$35.08M+6.0%
2017Dec 29, 2017$33.09M+42.9%
2016Dec 30, 2016$23.15M-61.4%
2015Dec 31, 2015$59.94M-55.2%
2014Dec 31, 2014$133.78M-7.4%
2013Dec 31, 2013$144.54M+55.3%
2012Dec 31, 2012$93.08M+81.9%
2011Dec 30, 2011$51.18M–

More Lisata Therapeutics figures

See a number that looks wrong?